Chemotherapy‐induced peripheral neurotoxicity (CIPN) is one of the most frequent and
severe long‐term side effects of cancer chemotherapy. Preclinical and clinical studies have …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common, potentially severe and
dose-limiting adverse effect of cancer treatment; however, the effects of CIPN on the daily life …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major clinical problem because
it represents the dose-limiting side-effect of a significant number of antineoplastic drugs [1] …

The peripheral nervous system can be vulnerable to the toxic action of several drugs since it
is not protected as effectively as the central nervous system from noxious exogenous agents …

Chemotherapy‐induced peripheral neurotoxicity (CIPN) is a potentially dose‐limiting side
effect of several commonly used cytotoxic chemotherapy agents. The main pharmacological …

Introduction: Prevention and treatment of chemotherapy-induced peripheral neurotoxicity
(CIPN) are clinically-relevant unmet needs. Despite extensive efforts at the preclinical and …

Opinion Statement Chemotherapy-induced peripheral neurotoxicity (CIPN) is one of the
most severe and unpredictable side effects of modern anticancer treatment. In recent years …

Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect caused by
several classes of widely used anticancer therapeutics. Chemotherapy-induced peripheral …

Chemotherapy-Induced Peripheral Neurotoxicity (CIPN) is a frequent, potentially severe and
dose-limiting side-effect of cancer treatment. Despite its clinical relevance that limits the use …

Chemotherapy-induced peripheral neurotoxicity (CIPN) has become a hot topic in
oncological daily practice. It is a common condition, related to chemotherapy regimen used …